IGC Pharma, Inc. (IGC): Operating Income

Annual figures by period end, from SEC filings.

Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$7.45M
Year ended 2025-03-31
-$8.09M
Trailing 12 months to 2025-09-30
2011-03-31: -$15.89M2012-03-31: -$7.51M2013-03-31: -$2.48M2014-03-31: -$2.53M2015-03-31: -$4.34M2016-03-31: -$2.91M2017-03-31: -$2.05M2018-03-31: -$1.79M2019-03-31: -$4.64M2020-03-31: -$6.86M2021-03-31: -$8.72M2022-03-31: -$15.43M2023-03-31: -$11.57M2024-03-31: -$9.80M2025-03-31: -$7.45M-$7.45M
2011-03-31 Operating Income (USD) 2025-03-31
Period endedOperating IncomeChange YoYSource filing
2025-03-31-$7.45Mn/m2025-06-27, From 2024-04-01
2024-03-31-$9.80Mn/m2025-06-27, From 2023-04-01
2023-03-31-$11.57Mn/m2024-06-24, From 2022-04-01
2022-03-31-$15.43Mn/m2023-07-07, From 2021-04-01
2021-03-31-$8.72Mn/m2022-06-23, From 2020-04-01
2020-03-31-$6.86Mn/m2021-06-14, From 2019-04-01
2019-03-31-$4.64Mn/m2020-07-13, From 2018-04-01
2018-03-31-$1.79Mn/m2019-06-14, From 2017-04-01
2017-03-31-$2.05Mn/m2018-06-21, From 2016-04-01
2016-03-31-$2.91Mn/m2017-07-14, From 2015-04-01
2015-03-31-$4.34Mn/m2016-07-14, From 2014-04-01
2014-03-31-$2.53Mn/m2015-07-14, From 2013-04-01
2013-03-31-$2.48Mn/m2014-07-15, From 2012-04-01
2012-03-31-$7.51Mn/m2014-07-15, From 2011-04-01
2011-03-31-$15.89Mn/a2012-07-16, From 2010-04-01